Objectives: This study was designed to compare the efficacy of iontophoresis and phonophoresis of dexamethasone sodium phosphate (Dex-P) treatment for mild to moderate carpal tunnel syndrome (CTS).
C arpal tunnel syndrome (CTS) is one of the most common peripheral neuropathies, 1 which is due to an entrapment of the median nerve in the carpal tunnel at the wrist area. Its prevalence is about 3% among women and 2% among men, with peak prevalence in women older than 55 years of age. 2 CTS results in considerable discomfort and pain, limitation of activities of daily living, loss of sleep, and work disability. 3 It is important to diagnose and treat CTS, because delay may result in irreversible median nerve damage with persistent symptoms and permanent disability. 4, 5 Various possibilities or treatment including surgical and conservative treatments have been used for CTS. [6] [7] [8] [9] [10] In a most recent systematic review study, authors showed that both surgical and conservative interventions had treatment benefits in CTS, with a superior effect of surgical treatment, 11 although some complications and side effects have also been reported. Conservative treatments include rest and avoidance of extreme activity with the hand, ultrasound and laser therapy, splinting the wrist in a neutral position, nonsteroidal anti-inflammatory drugs, oral steroids, local corticosteroid injections, and surgery to decompress the median nerve segment. 5 Iontophoresis and phonophoresis methods were also used to introduce locally the anti-inflammatory steroid drugs for CTS treatment. 9, [12] [13] [14] [15] However, there are some controversies about the reported results by these studies. In 1994, Banta 16 suggested that iontophoresis may become an alternative to steroid injections to the carpal tunnel region. Later, Dakowicz and Latosiewicz 14 showed that using a combination of hydrocortisone iontophoresis and ultrasound therapy may diminish the symptoms of patients with mild to moderate CTS. Gokoglu et al 13 also reported a successful treatment by iontophoresis of dexamethasone sodium phosphate (Dex-P) in patients with CTS. In 2 separate studies, no superiority was reported between iontophoresis and phonophoresis methods to deliver betamethasone or corticosteroid drugs for CTS treatment. 12, 17 In 2009, Amirjani et al 15 showed that iontophoresis of 0.4% dexamethasone is not effective in the treatment of mild to moderate CTS. In view of these studies, our objective was to identify whether there is any beneficial effect from iontophoresis and phonophoresis of 4% Dex-P in patients with mild to moderate CTS.
MATERIALS AND METHODS
A randomized clinical trial with concealed allocation, intention-to-treat analysis, and assessor blinding was approved by the ethical committee of the University and conducted in the Neuromuscular Rehabilitation Research Centre. Thirty-four patients (18 patients with both wrists affected and 16 patients with 1 wrist affected on the right side) clinically diagnosed with CTS referred to the University physiotherapy clinics were invited to participate in this clinical trial. All patients were right handed and gave their consent to participate. All patients with numbness in the median nerve distribution and night waking lasting more than 1 month were enrolled in the study. The inclusion criteria were (1) positive Phalen test; (2) positive Tinnel test; (3) standard electrophysiological criteria including prolongation of median nerve conduction velocity (ie, motor distal latency >4.0 ms or sensory distal latency >3.5 ms 18 ; and (4) normal sensory and motor conduction latency within the ulnar nerve. Patients were excluded if they had secondary entrapment neuropathies, electroneurographic signs including motor distal latency >5.5 ms or sensory distal latency >5.0 ms, and clinical signs of axonal degeneration of the median nerve such as thenar eminence atrophy, 18 if they had been treated with ultrasound or low-level laser therapy for the syndrome, or had required regular analgesic or anti-inflammatory drugs. Patients with a history of steroid injection into the carpal tunnel, thyroid disease, diabetes, or systemic peripheral neuropathy were also excluded. An individual interview was carried out to collect demographic and physical assessment data. After their eligibility was confirmed, participants were randomly allocated to 1 of the 2 experimental groups.
As there were 2 categories of CTS patients, patients with bilateral involvement and patients with unilateral involvement, a computer generated a randomized list for group assignment. The list had a block size of 30, but was provided to the recruiting investigators in sealed opaque envelopes. After each participant's eligibility and informed consent were confirmed, according to their bilateral or unilateral involvement, the appropriate numbered envelope was opened at the reception; the card inside indicated the patient's allocation to a treatment group. Cards allocating the participant to the experimental groups were then given to the physiotherapists who administered iontophoresis or phonophoresis interventions.
Patients with both wrists affected were assigned randomly to 1 of the 2 following treatment groups: group A, who received iontophoresis intervention in both right and left hands or group B, who received phonophoresis intervention in both right and left hands. The patients with 1 wrist affected were also assigned randomly to the following treatment groups: group A, who received iontophoresis intervention or group B, who received phonophoresis. The affected side in all patients with 1 wrist involved was the right side. Using these randomization procedures, 52 wrists were randomly enrolled in each of the treatment protocols, iontophoresis or phonophoresis intervention, and the numbers of dominant and nondominant hands in each treatment group were equal.
Intervention
Participants in both experimental groups received 10 treatment sessions of either iontophoresis or phonophoresis of 0.4% Dex-P on their wrist region. 15, 19 In the iontophoresis group, they received 0.4% Dex-P using direct current, which applied up to 2 mA/min, and a total dose of 40 mA/ min for 20 minutes over the wrist chin. A negative electrode, (3Â 4 cm) of the same polarity as the ion, was placed on the line of the wrist; a positive electrode (5Â 6 cm) was placed on the dorsal aspect of the forearm. Galvanic current (Phyaction Model 787) was used for ion transfer. The apparatus was initially standard and the output of the stimulator was controlled regularly by a simple oscilloscope. In the phonophoresis group, 4 g of Aquasonic gel containing 0.4% Dex-P was applied over the wrist chin, and pulsed (20%) ultrasound waves (ITO model ES-420 with 5-cm 2 probe) were used with an intensity of 1.0 W/cm 2 at a 1 MHz frequency for 5 minutes to transfer the medication. 19, 20 The apparatus was initially calibrated and the output was controlled regularly by a simple under-water radiation balance. This therapy was applied for 5 min/session, 5 d/wk, for 2 weeks.
Outcome Measures
The staff who assessed the outcomes were different from the staff administering the treatments, and they were blinded to the type of treatment (iontophoresis or phonophoresis) each patient had received. Outcome measures for each wrist consisted of the following: (1) pain measurement by means of a visual analogue scale, on which the patients could indicate their assessment along a 10-cm line ranging from 0 (no pain at all) to 10 (the most severe pain that I can imagine); (2) the pinch strength was measured with a pinch gauge (North Coast Hydraulic Pinch Gauge), the buttons on which were pressed between the tips of the thumb and the little finger; and (3) hand grip strength was measured with a hand-held dynamometer (Jamar Hydraulic Hand Dynamometer), the handles of which were pressed by the patient's hand. The dynamometers were initially standard and the sensitivity was controlled regularly by standard weights. To measure pinch and grip strengths, the patients were asked to sit in a standard position and they were ordered to press the buttons or handles of the pinch gauge or hand-held dynamometer as hard as possible for 5 seconds. This was repeated 3 times with a 30 second rest between each repetition. The maximum force exerted was considered as the strength of pinch or hand grip.
All electroneurographic measurements were performed with a portable Dantec electromyography device (Keypoint Portable). In brief, median motor nerve conduction and distal motor latency were measured with a bipolar stimulating electrode at the wrist and a bipolar surface recording electrode placed on the abductor pollicis muscle 7 cm from the stimulus electrodes at the wrist. The active electrode was placed halfway between the metacarpophalangeal joint of the thumb and the midpoint of the distal wrist crease, so the recorded site was the same for all recording sessions. Motor distal latency was calculated from the onset of compound muscle action potential, the negative peak of which was considered as the compound muscle action potential amplitude.
Antidromic sensory nerve action potentials evoked at the wrist were recorded from the thumb and the index finger with ring electrodes placed around the thumb proximal and distal interphalangeal joints. A standard distance (14 cm) was maintained between the stimulator and the recording electrodes. At least 20 sensory nerve action potentials were averaged and antidromic sensory nerve latencies were calculated from the peak of the sensory action potential, as appropriate. The sensory amplitude was obtained from 1 peak to another of the sensory action potential. The skin temperature of the forearm and the wrist were kept at 32 to 331C during all measurements.
All measurements were performed before the first treatment session, at the end of therapy, and after 4 weeks' follow-up to compare the effects of the 2 different treatments. To reduce the number lost to follow-up, we guaranteed to complete the treatment regimen with more effective treatments if there was no benefit from the applied treatment at the end of the study. Thus, all patients completed the study to the end of the 4-week follow-up period.
Statistics
To compare the possible treatment effect, an intentionto-treat analysis was used, which involved all patients who were randomly assigned to their groups. Baseline characteristics were analyzed using descriptive statistics and are presented as means with SDs. Student t tests were used to compare the means of the electrophysiological values, pain, and finger pinch and hand grip strength between the treatment groups, before and immediately after the treatment, and then 4 weeks later. Significance level was set a priori at P < 0.05.
RESULTS
Thirty-four patients with mild to moderate CTS (52 affected hands) were randomly assigned in the phonophoresis (26 hands) or iontophoresis (26 hands) groups. Eighteen patients with bilateral CTS and 16 patients with unilateral CTS (52 wrists) fulfilled all inclusion criteria. Thus, 26 wrists treated with phonophoresis and 26 wrists treated with iontophoresis completed a 2-week (10 sessions) treatment protocol and 4-week follow-up period.
The wrists in each group were similar in terms of the duration of the current main symptoms and baseline values of outcome measures. No significant difference was seen between the demographic data and baseline characteristics of patients in the iontophoresis and the phonophoresis groups ( Table 1 ). Table 2 shows the mean changes before and after therapy and 4 weeks later in the subjective and objective measurements. Significant differences were seen in the mean changes of all measurements between the 2 experimental groups.
Effect of Treatment

Physical Functioning
Measures of finger pinch and hand grip strength showed significant improvement in both groups, but the mean changes were significantly higher with phonophoresis of Dex-P at the end and also at 4 weeks' follow-up ( Table 2) .
Pain Perception
Patients' ratings of pain at the end of the treatment and 4 weeks later significantly favored phonophoresis over iontophoresis of Dex-P intervention (P < 0.01).
Electroneurography
The results of electroneurography tests are shown in Table 2 . Motor distal latency decreased in both experimental groups, whereas the mean changes were significantly greater with phonophoresis of Dex-P intervention both at the end of the treatment and at 4 weeks' follow-up (P < 0.001 for both periods). Similar significant changes in the sensory distal latency were observed with phonophoresis treatment, whereas sensory distal latency remained unchanged with iontophoresis of Dex-P (P < 0.001 for both periods). The amplitude of the motor and the sensory action potentials increased significantly in the phonophoresis groups, at the end of the treatment and at 4 weeks' follow-up compared with the iontophoresis of the Dex-P intervention group (Table 2) .
DISCUSSION
This study examined the results of the effect of phonophoresis and iontophoresis of Dex-P in patients who had CTS confirmed by clinical examination and electroneurography. There were significantly greater changes in all parameters for the phonophoresis of Dex-P compared with the iontophoresis group. Although greater mean changes were found consistently in the phonophoresis group, the size of mean differences was different for different outcomes. For example, whereas the mean differences in the effects on finger pinch strength were large, the mean differences on hand grip strength were small ( Table 2 ). The differences between treatment effects on finger pinch and hand grip strength may be due to the different muscles involved. For example, the main muscles to produce the force in a pinch between the thumb and the little finger are opponens pollicis and flexor pollicis brevis, which are innervated only by the median nerve. In hand grip strength, different types of muscles with different innervations are responsible for the generated force, 21 and so this measurement could be varied according to the patient's ability to Data are means (SD), except where indicated. CMAP indicates compound motor action potential; SAP, sensory action potential. use other muscles innervated by the ulnar nerve to overcome the grip weakness caused by median nerve involvement. The other possible reason for the difference between treatment effects could be the fact that the pinch and grip strength may not be affected in the milder CTS patients, and so the therapy results in no improvement in these parameters. Therefore, considering the existence of some milder CTS patients, this uncontrolled variable may interfere with the recorded values and cause smaller mean differences with grip strength compared with pinch strength.
It has been claimed that conservative treatment approaches such as splinting, ultrasound, and low-level laser therapies seem to offer clear advantages in patients with mild or moderate CTS. 22 Recent studies have shown shortterm effects of steroid injections into the carpal tunnel, with modest or complete pain relief in up to 92% of the patients, [23] [24] [25] although the value of this treatment has been limited by potential adverse effects to nerves and tendons with repeated injection. [26] [27] [28] Some studies have reported some beneficial effects of noninvasive methods such as iontophoresis or phonophoresis to introduce anti-inflammatory drugs locally within the carpal tunnel region in patients with mild to moderate CTS. 6, 14, 19 They have claimed that these interventions may facilitate the recovery from CTS, although there are some contradictory results from other studies. 13, 15 The findings of the present study confirm that the phonophoresis of Dex-P treatment is more effective than the iontophoresis of Dex-P treatment in patients with CTS. These findings were similar to those reported in other studies, 10, 29 and may indicate its similar effectiveness to steroid injection or wrist splinting, 30, 31 but without their complications. 26, 27 For the first time, Banta 16 used iontophoresis of antiinflammatory medication in the treatment of CTS and suggested that iontophoresis may become an alternative to steroid injections to the carpal tunnel region, whereas Aygul et al 17 showed the superior effect of steroid injection to iontophoresis and phonophoresis in the treatment of CTS. Although a few studies have investigated the effect of iontophoresis and phonophoresis of Dex-P on CTS, a wide range of therapeutic parameters such as wave length, exposure intensity, and different methods of local application was applied by these investigations. For example, Gokoglu et al 13 showed that daily application of iontophoresis of 0.4% Dex-P (for 1 wk) by a galvanic current of 40 to 45 mA for 20 minutes/session may significantly improve the clinical examination variables, pain, symptom severity, and functional status in CTS patients. In another study by Akinbo et al, 19 10 minutes of direct current to induce 0.4% Dex-P phonophoresis or 5 minutes of 1 MHz ultrasound to induce 0.4% Dex-P iontophoresis showed functional performance improvement in both groups, whereas no superiority was found between these 2 methods. Amirjani et al 15 used iontophoresis of 0.4% Dex-P (a dose of 80 mA/min continuous DC current at a rate of 2 mA/min, treatment sessions on alternate days over a 2-wk period) to treat mild to moderate CTS and reported no superior effect to the iontophoresis protocol compared with the placebo group. In 2009, Karatay et al 9 used phonophoresis of 0.1% Dex-P pomade by ultrasound (1 MHz frequency, 1 W/cm 2 intensity, pulsed mode: 1:4, with a transducer of 5 cm 2 , 10 min/session) and iontophoresis of 0.4% Dex-P by galvanic current (1 to 4 mA, 10 min/session). They reported significant improvement in clinical parameters including functional status and symptom severity in both iontophoresis and phonophoresis groups, but no change was found in terms of the electrophysiological parameters. In 2010, Gurcay et al 12 also compared iontophoresis and phonophoresis with 0.1% betamethasone in patients on CTS treatment and reported significant reduction in the symptom severity in the phonophoresis group. Ultrasound parameters in the phonophoresis group were 1 MHz and an intensity of 1 W/cm 2 , in the continuous mode, whereas the iontophoresis group received 0.1% betamethasone from the positive electrode at a dosage of 2 mA for 10 min/d (9 sessions, 3 d/wk, for 3 wk). Such different reports on the effects of iontophoresis and phonophoresis of Dex-P may be due to the different therapeutic parameters that have been applied in these studies and it seems that there is no general agreement on the therapeutic parameters of these interventions for the treatment of CTS. In our study, the comparison between the findings from iontophoresis of Dex-P and those from phonophoresis of Dex-P illustrates the superior effect of phonophoresis on recovery, which has also been reported by other studies. 6, 9 Phonophoresis of Dex-P could elicit anti-inflammatory and tissue-stimulating effects, as already shown in clinical trials. 19, 32 By this method, phonophoresis has the potential to accelerate normal resolution of inflammation. 12 The results of these studies confirm that phonophoresis of Dex-P therapy may accelerate the healing process in damaged tissues. These mechanisms may explain our findings that showed phonophoresis of Dex-P therapy relieved pain, increased grip strength, and changed electrophysiological parameters toward normal values better than iontophoresis of Dex-P in patients with mild to moderate CTS diagnosis.
CONCLUSIONS
Our clinical trials showed that phonophoresis of Dex-P is more effective than iontophoresis of Dex-p treatment in patients with mild to moderate CTS. Further research is required to investigate the long-term efficacy of phonophoresis versus iontophoresis, and whether the combination of these 2 treatments is superior to either treatment alone.
